Rare diseases
Investigational molecules
Locations
Back to France6 clinical trials in Guilherand-Granges, France. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in FranceEssaisCliniques.fr(opens in a new tab)FranceFranceFranceFranceFranceFranceThe busiest research cities in the country
What the registry says about research in the country
Innovative studies focusing on hormone-sensitive breast cancer treatment optimization, particularly examining reduced therapy durations for low-risk patients.
Additional research explores combining everolimus with standard treatments for ER+ and HER2- breast cancer patients.
Advanced research in prostate cancer treatment, evaluating combination therapies including radiation and darolutamide for patients with oligometastatic disease.
Investigations include novel imaging techniques for precise treatment planning.
Pioneering research in chemotherapy optimization for gastrointestinal cancer patients, focusing on personalized dosing strategies.
Studies aim to develop precise guidelines for patients with specific enzyme deficiencies.
Clinical investigations of squamous cell carcinoma treatments, testing new therapeutic combinations with radiotherapy.
Research focuses on improving outcomes for high-risk patients ineligible for standard treatments.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
